InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Discover the detailed record of transactions filed by Sachs Jessica, Directeur Médical. Insider active across 1 company, notably Cogent Biosciences, Inc.. Aggregated, 4 filings have been published. Split: 0 buy · 1 sell. Total volume traded: €2.7m. Activity tracked since 31 December 2021. The latest transaction was disclosed on 26 December 2025 (Cession). Regulator: SEC (Form 4). All data is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 条申报中的 4 条
Jessica Sachs is the Chief Medical Officer at Cogent Biosciences, Inc. She is responsible for leading the company's medical and scientific initiatives. Her expertise in biotechnology and clinical research is essential for the development of new treatments. She plays a key role in guiding Cogent Biosciences' medical strategies.